Personalized cancer chemotherapy: an effective way of enhancing outcomes in clinics
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Cambridge, UK
Elsevier/Woodhead Publishing
[2015]
|
| Schriftenreihe: | Woodhead Publishing series in biomedicine
|
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Beschreibung: | Includes bibliographical references Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists |
| Beschreibung: | 1 Online-Ressource (85 pages) |
| ISBN: | 9780081003473 0081003471 9780081003466 0081003463 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043216222 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151216s2015 |||| o||u| ||||||eng d | ||
| 020 | |a 9780081003473 |9 978-0-08-100347-3 | ||
| 020 | |a 0081003471 |9 0-08-100347-1 | ||
| 020 | |a 9780081003466 |9 978-0-08-100346-6 | ||
| 020 | |a 0081003463 |9 0-08-100346-3 | ||
| 035 | |a (OCoLC)898423398 | ||
| 035 | |a (DE-599)BVBBV043216222 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 | ||
| 082 | 0 | |a 615.58 |2 23 | |
| 100 | 1 | |a Lu, Da-Yong |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Personalized cancer chemotherapy |b an effective way of enhancing outcomes in clinics |c Da-Yong Lu |
| 264 | 1 | |a Cambridge, UK |b Elsevier/Woodhead Publishing |c [2015] | |
| 300 | |a 1 Online-Ressource (85 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Woodhead Publishing series in biomedicine | |
| 500 | |a Includes bibliographical references | ||
| 500 | |a Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists | ||
| 650 | 7 | |a MEDICAL / Pharmacology |2 bisacsh | |
| 650 | 7 | |a Cancer / Treatment |2 fast | |
| 650 | 7 | |a Chemotherapy |2 fast | |
| 650 | 4 | |a Neoplasms / drug therapy | |
| 650 | 4 | |a Individualized Medicine / methods | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Chemotherapy | |
| 650 | 4 | |a Cancer |x Treatment | |
| 856 | 4 | 0 | |u http://www.sciencedirect.com/science/book/9780081003466 |x Verlag |3 Volltext |
| 912 | |a ZDB-33-ESD |a ZDB-33-EBS | ||
| 940 | 1 | |q FLA_PDA_ESD | |
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028639246 | ||
Datensatz im Suchindex
| _version_ | 1804175720925102080 |
|---|---|
| any_adam_object | |
| author | Lu, Da-Yong |
| author_facet | Lu, Da-Yong |
| author_role | aut |
| author_sort | Lu, Da-Yong |
| author_variant | d y l dyl |
| building | Verbundindex |
| bvnumber | BV043216222 |
| collection | ZDB-33-ESD ZDB-33-EBS |
| ctrlnum | (OCoLC)898423398 (DE-599)BVBBV043216222 |
| dewey-full | 615.58 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 615 - Pharmacology and therapeutics |
| dewey-raw | 615.58 |
| dewey-search | 615.58 |
| dewey-sort | 3615.58 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>02536nmm a2200469zc 4500</leader><controlfield tag="001">BV043216222</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151216s2015 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780081003473</subfield><subfield code="9">978-0-08-100347-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0081003471</subfield><subfield code="9">0-08-100347-1</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9780081003466</subfield><subfield code="9">978-0-08-100346-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">0081003463</subfield><subfield code="9">0-08-100346-3</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)898423398</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043216222</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">615.58</subfield><subfield code="2">23</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Lu, Da-Yong</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Personalized cancer chemotherapy</subfield><subfield code="b">an effective way of enhancing outcomes in clinics</subfield><subfield code="c">Da-Yong Lu</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Cambridge, UK</subfield><subfield code="b">Elsevier/Woodhead Publishing</subfield><subfield code="c">[2015]</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (85 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Woodhead Publishing series in biomedicine</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">MEDICAL / Pharmacology</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Cancer / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Chemotherapy</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Neoplasms / drug therapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Individualized Medicine / methods</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Chemotherapy</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Cancer</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://www.sciencedirect.com/science/book/9780081003466</subfield><subfield code="x">Verlag</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-33-ESD</subfield><subfield code="a">ZDB-33-EBS</subfield></datafield><datafield tag="940" ind1="1" ind2=" "><subfield code="q">FLA_PDA_ESD</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028639246</subfield></datafield></record></collection> |
| id | DE-604.BV043216222 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:20:47Z |
| institution | BVB |
| isbn | 9780081003473 0081003471 9780081003466 0081003463 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028639246 |
| oclc_num | 898423398 |
| open_access_boolean | |
| owner | DE-1046 |
| owner_facet | DE-1046 |
| physical | 1 Online-Ressource (85 pages) |
| psigel | ZDB-33-ESD ZDB-33-EBS FLA_PDA_ESD |
| publishDate | 2015 |
| publishDateSearch | 2015 |
| publishDateSort | 2015 |
| publisher | Elsevier/Woodhead Publishing |
| record_format | marc |
| series2 | Woodhead Publishing series in biomedicine |
| spelling | Lu, Da-Yong Verfasser aut Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics Da-Yong Lu Cambridge, UK Elsevier/Woodhead Publishing [2015] 1 Online-Ressource (85 pages) txt rdacontent c rdamedia cr rdacarrier Woodhead Publishing series in biomedicine Includes bibliographical references Individualized cancer chemotherapy (ICC) has been designed to meet the requirement of selecting anticancer drugs in clinics and attracting increasing attentions in medical circle and will show more beneficial outcome in the future if we stick on these researches. Personalized Cancer Chemotherapy addresses and reviews this issue by discussing many existing specific strategies of ICC, including drug sensitivity testing, cancer biomarker detections, cancer biomarker-oriented therapy, anticancer drug pharmacogenetics, cancer metastasis therapy, anticancer drug combinations, assistant therapy, mathematics, and computational analysis of cancer malignancy and drug responses, cost effective and finally studies of relationship between different ICC strategies. The relationship between drug response and these techniques or methods is in-depth analyzed, discussed and highlight. Many longstanding key debates and future trends are also intensively discussed, highlighted and debuted with new twists MEDICAL / Pharmacology bisacsh Cancer / Treatment fast Chemotherapy fast Neoplasms / drug therapy Individualized Medicine / methods Medizin Chemotherapy Cancer Treatment http://www.sciencedirect.com/science/book/9780081003466 Verlag Volltext |
| spellingShingle | Lu, Da-Yong Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics MEDICAL / Pharmacology bisacsh Cancer / Treatment fast Chemotherapy fast Neoplasms / drug therapy Individualized Medicine / methods Medizin Chemotherapy Cancer Treatment |
| title | Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics |
| title_auth | Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics |
| title_exact_search | Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics |
| title_full | Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics Da-Yong Lu |
| title_fullStr | Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics Da-Yong Lu |
| title_full_unstemmed | Personalized cancer chemotherapy an effective way of enhancing outcomes in clinics Da-Yong Lu |
| title_short | Personalized cancer chemotherapy |
| title_sort | personalized cancer chemotherapy an effective way of enhancing outcomes in clinics |
| title_sub | an effective way of enhancing outcomes in clinics |
| topic | MEDICAL / Pharmacology bisacsh Cancer / Treatment fast Chemotherapy fast Neoplasms / drug therapy Individualized Medicine / methods Medizin Chemotherapy Cancer Treatment |
| topic_facet | MEDICAL / Pharmacology Cancer / Treatment Chemotherapy Neoplasms / drug therapy Individualized Medicine / methods Medizin Cancer Treatment |
| url | http://www.sciencedirect.com/science/book/9780081003466 |
| work_keys_str_mv | AT ludayong personalizedcancerchemotherapyaneffectivewayofenhancingoutcomesinclinics |